HeyJaredhealthtechbuilders
musings on why it's the best time to be an entrepreneur in healthcare.
- Indexed issues, last 90 days
- 5
- Latest publication
- Sep 12, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 15, 2026
Latest issues
Employers Are Shopping For A New Health Plan (opens the original)
Read excerpt
There's generational replacement cycle happening in the commercial health plan market, and a previously impenetrable category is now addressable for startups. It's one of the largest markets in healthtech, and a control vector for how healthcare is priced, accessed, and experienced.3 forces are converging:1. Employers can no longer stomach the year-over-year rises in premiums and overall healthcare costs.2. Consumers have tasted something better with DTC care and AI-native services.3. AI is chan
MTS: Healthcare is Skipping 20 Years of Software (opens the original)
Mavericks in Healthcare (opens the original)
Read excerpt
Fun convo with Ajay Mody and Asher Perzigian about this being the best time to be a builder in healthtech:[14:45] Healthcare AI adoption has been organic, not mandated like prior health tech eras. Unlike EHRs, interoperability, and telehealth, this wave isn’t being driven by regulation, penalties, or a pandemic. cc: Ambience, Abridge, Bayesian<
Be AI-Native and AI-Proof (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="512" src="https://substackcdn.com/image/fetch/$s_!R2qe!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F576048e0-3bea-4281-bce0-b80e96142958_1024x512.png"
Clinical AI on Hard Mode (opens the original)
Read excerpt
A masterclass by Suchi Saria about building clinical AI on hard mode: achieving FDA breakthrough designation and de novo clearance (”we treat FDA not as the ceiling, but as the floor”), earning CMS NTAP reimbursement, getting clinicians to trust your tech and make high-stakes decisions based on its outputs, validating and generalizing an AI model to work at population scale, and focusing on the use cases that represent the biggest drivers of mortality and utilization. Her company <sp
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.